Consolidated Guidelines

1.1.1 Target Audience and Scope:

The main target audience for these policy guidelines consists of policy makers in member states as well as all employers of health workers. The recommended policy guidelines are expected to be useful for health and labour departments, regional policy-makers, health facility managers, and all front-line health workers - including informal health givers. It is expected that these guidelines will also be useful to representatives of health workers, including unions and health professional associations, as well as occupational health and infection control practitioners.

Annex 2: Follow-up and implementation; an Extract from the Report: International consultation policy guidelines on improving health workers' access to prevention, treatment and care services for HIV and TB 14-16 September 2009, WHO/Geneva (pp 41-46)

General Results of Guideline Group discussions and agreements

There is consensus among members of the Guideline Group that there is a need for a policy guideline from WHO/ILO

In the end, participants reached consensus, accepting 14 statements as a policy guideline. Countries can take statements and create advocacy material or collaborate with existing strategies already in place to increase access for Health Care Workers (HCWs).

Annex 1: WHO and other international guidelines referenced

EngenderHealth.(2004). Reducing stigma and discrimination related to HIV and AIDS: training for health care workers. New York.

EngenderHealth and United Nations Population Fund. (2008) Sexual and Reproductive Health of Women and Adolescent Girls: Guidance for health managers, health workers, and activists. Available from: http://www.engenderhealth.org/files/pubs/hiv-aids-stis/english-srh-guidance-final.pdf

References

Adams J, Bartram J, Chartier Y. (2008). Essential environmental health standards in health care. Geneva, Switzerland. World Health Organization.

Anglaret X et al. (1999). Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1 infected adults in Abidjan, Cote d' Ivoire: a randomised trial. Cotrimo-CI study group. Lancet. 353:1463-1468.

2.14.2 Key References and Supporting ILO and WHO Guidelines

Dement, J. M., Pompeii, L. A., Ostbye, T., Epling, C., Lipscomb, H. J., James, T., et al. (2004). An integrated comprehensive occupational surveillance system for health care workers. American Journal of Industrial Medicine, 45(6), 528-538.

Hood, J., & Larranaga, M. (2007). Employee health surveillance in the health care industry. AAOHN Journal: Official Journal of the American Association of Occupational Health Nurses, 55(10), 423­431.

2.13.2 Key References and Supporting WHO Guidelines

International Labour Office. (1998). Technical and ethical guidelines for workers' health surveillance (OSH n72). Geneva, Switzerland: ILO.

Sagoe-Moses, C., Pearson, R. D., Perry, J., & Jagger, J. (2001). Risks to health care workers in developing countries. The New England Journal of Medicine, 345(7), 538-541.

Tereskerz PM, Jagger J. (1997) Occupationally acquired HIV: the vulnerability of health care workers under workers' compensation laws. Am J Public Health, 87:1558-1562

Supported by Existing Guidelines:

2.12.2 Key References and Supporting WHO Guidelines

Anglaret X et al. (1999) Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1 infected adults in Abidjan, Cote d' Ivoire: a randomised trial. Cotrimo-CI study group. Lancet. 353:1463-1468.

Badri, M., Ehrlich, R., Wood, R., & Maartens, G. (2001). Initiating co-trimoxazole prophylaxis in HIV-infected patients in africa: An evaluation of the provisional WHO/UNAIDS recommendations. AIDS (London, England), 15(9), 1143-1148.

2.10.2 Key References and Supporting WHO Guidelines

Baraboutis, I.F., Papastamopoulos, V., Georgious, O., Samarkos, M., Vrionis, E., Kotsianopoulou, M., Skeoutelis, A.T. (2010) Expanded postexposure prophylaxis for simultaneous multiple source HIV exposure in a health-care worker. IntJ STD AIDS, 21:147-148.

Corbett, L. (2007). Health worker access to HIV/TB prevention, treatment and care services in Africa: Situational analysis and mapping of routine and current best practices. Unpublished manuscript.

2.9.2 Key References and Supporting WHO Guidelines

Badri, M., Cleary, S., Maartens, G., Pitt, J., Bekker, L. G., Orrell, C., et al. (2006). When to initiate highly active antiretroviral therapy in Sub-Saharan Africa? A South African cost-effectiveness study. Antiviral Therapy, 11(1), 63-72.

Badri, M., Ehrlich, R., Wood, R., & Maartens, G. (2001). Initiating co-trimoxazole prophylaxis in HIV-infected patients in africa: An evaluation of the provisional WHO/UNAIDS recommendations. AIDS (London, England), 15(9), 1143-1148.